Olema Pharmaceuticals, Inc.

OLMA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$139,480$68,539$23,702$13,812
Short-Term Investments$294,606$193,268$180,719$273,438
Receivables$2,120$673$319$130
Inventory$0$0$0$0
Other Curr. Assets$2,267$4,033$4,159$3,305
Total Curr. Assets$438,473$266,513$208,899$290,685
Property Plant & Equip (Net)$2,060$3,259$3,975$4,720
Goodwill$0$0$0$0
Intangibles$683$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$9,763$7,173$2,771$540
Total NC Assets$12,506$10,432$6,746$5,260
Other Assets$0$0$0$0
Total Assets$450,979$276,945$215,645$295,945
Liabilities
Payables$4,460$2,698$374$23
Short-Term Debt$1,172$988$1,015$931
Tax Payable$41$73$68$88
Deferred Revenue$0$0$0$0
Other Curr. Liab.$36,085$17,862$15,092$7,977
Total Curr. Liab.$41,758$21,621$16,549$9,019
LT Debt$257$1,429$1,550$2,358
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$257$1,429$1,550$2,358
Other Liabilities$0$0$0$0
Cap. Leases$1,429$2,417$2,565$3,289
Total Liabilities$42,015$23,050$18,099$11,377
Equity
Pref Stock$0$0$0$0
Common Stock$6$4$3$3
Retained Earnings-$435,106-$305,632-$208,977-$104,190
AOCI$143$347-$1,813-$149
Other Equity$843,921$559,176$408,333$388,904
Total Equity$408,964$253,895$197,546$284,568
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$450,979$276,945$215,645$295,945
Net Debt-$138,051-$66,122-$21,137-$10,523
Olema Pharmaceuticals, Inc. (OLMA) Financial Statements & Key Stats | AlphaPilot